How many boxes of Erdafitinib need to be taken in a month and how much does the treatment cost?

The dosage of Erdafitinib (Erdafitinib) is adjusted according to the tolerance of bladder cancer patients, so "how many boxes are needed in a month" cannot be generalized. However, according to the commonly used starting regimen - the starting dose is 8mg, once daily, and can be increased to 9mg on days 14 to 21 depending on tolerance (especially blood phosphorus levels), the average patient's monthly usage roughly revolves around "1 tablet per day". Combining common strengths of 4mg, 5mg, and 3mg, most patients require approximately 1-2 boxes per month, depending on the dosage combination and strength supply.

In terms of cost, the version commonly used in clinical practice is The original version of the drug in Hong Kong is not included in medical insurance, so the out-of-pocket cost is relatively high, generally above 20,000 yuan, and may even fluctuate due to differences in channels. The original drug has high supply stability and strict quality, and is the version recommended by most doctors.

Overseas generic drugs include the Laos version and the Bangladeshi version. Due to different policies and market models in the producing countries, the price is generally much lower than that of the original drug, ranging from a few hundred to 2,000 yuan, making it suitable for patients with greater financial pressure as an alternative. It needs to be emphasized that these generic drugs are usually compounded based on the ingredients of the original research overseas. The ingredients and dosage design are basically the same as those of the original research. However, there may be differences in stability, impurity control and global certification systems, so the choice of channels needs to be cautious.

No matter which dosage form or version you choose, you should follow the three principles of "gene testing matching - standardized prescription - testing and monitoring" Erdafitinib is based on FGFR3 alterations, so only patients who clearly carry the susceptibility gene can benefit from it. During the medication period, indicators such as serum phosphorus, adverse reactions, eye symptoms, etc. should be monitored regularly to adjust the dose in a timely manner and avoid interrupting treatment due to side effects.

Generally speaking, the number of boxes required per month depends on the dosage, and the cost varies with the choice of original and generic. Patients should combine budget, accessibility and formal channels, communicate with their attending doctors, and choose the treatment method that best suits them.

References：https://www.balversa.com/